Results from a small randomized controlled clinical trial show promising findings about a new type of therapy for patients ...

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...

Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...

A Nature Medicine study found that healthy Australian adults were widely exposed to plastic-associated chemicals, with ...

The 58 participant, randomized, double-blind, placebo-controlled study was led by Edmarie Guzmán-Vélez, PhD, formerly an Assistant Professor in the Department of Psychiatry and the McCance Center for ...

Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of ...

NEW YORK - Oncolytics Biotech Inc. (NASDAQ:ONCY) announced alignment with the U.S. Food and Drug Administration on the design of a pivotal clinical study for pelareorep in patients with unresectable ...

Carica papaya leaf extract (CPLE) versus placebo to improve chemotherapy induced thrombocytopenia (CIT): Results of a phase III triple blinded, randomized placebo controlled trial (PACT study).

Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...

As a medical student and researcher, I was shocked by the brazen inequity of the trial.  Randomized controlled trials have ...